Author:
Meng Sihan,Gao Yu,Qiang Guowei,Hu Zhiwei,Shan Qi,Wang Juxian,Wang Yucheng,Mou Jie
Funder
Foundation for Innovative Research Groups of the National Natural Science Foundation of China
Reference38 articles.
1. HIV-1 protease inhibitors with a P1 phosphonate modification maintain potency against drug-resistant variants by increased interactions with flap residues;Lockbaum;European Journal of Medicinal Chemistry,2023
2. HIV-protease inhibitors;Flexner;The New England Journal of Medicine,1998
3. HIV Protease: Historical Perspective and Current Research;Weber;Viruses,2021
4. Spielvogel, E.; Lee, S. K.; Zhou, S.; Lockbaum, G. J.; Henes, M.; Sondgeroth, A.; Kosovrasti, K.; Nalivaika, E. A.; Ali, A.; Yilmaz, N. K.; Schiffer, C. A.; Swanstrom, R., Selection of HIV-1 for resistance to fifth-generation protease inhibitors reveals two independent pathways to high-level resistance. eLife 2023, 12.